Glycopatterns and Glycoproteins Changes in MCN and SCN: A Prospective Cohort Study

Table 3

The protein enrichment by WGA in MCN versus SCN.

Protein name	Gene name	Majority protein IDs	Normalized relative intensity		MCN/SCN; Ratio
			MCN	SCN
(A) Increased expression
Ceruloplasmin	CP	P00450	3.58 ± 0.45	2.38 ± 0.15	1.50
Haptoglobin	HP	P00738-2	21.43 ± 1.85	11.86 ± 1.31	1.81
Apolipoprotein A-I	APOA1	P02647	203.23 ± 0.80	163.91 ± 9.36	1.24
Fibrinogen beta chain	FGB	P02675	55.94 ± 5.12	32.06 ± 1.62	1.74
Serotransferrin	TF	P02787	47.99 ± 0.83	28.92 ± 4.17	1.66
Protein S100-A9	S100A9	P06702	4.82 ± 0.38	2.08 ± 0.28	2.32
Clusterin	CLU	P10909-4	9.19 ± 0.84	6.99 ± 0.42	1.32
Actin gamma 1	ACTG1	P63261	3.69 ± 0.30	2.59 ± 0.27	1.43
(B) Decreased expression
Serpin peptidase inhibitor clade A member 1	SERPINA1	P01009	41.05 ± 2.37	53.74 ± 2.02	0.76
Alpha-1-antichymotrypsin	AACT	P01011	3.88 ± 0.22	7.91 ± 0.52	0.49
Alpha-2-macroglobulin	A2M	P01023	15.58 ± 2.81	33.14 ± 3.32	0.47
Immunoglobulin heavy constant alpha 1	IGHA1	P01876	27.16 ± 3.34	43.11 ± 7.02	0.63
Apolipoprotein A-II	APOA2	P02652	44.02 ± 1.52	49.89 ± 2.11	0.88
Complement component 9	C9	P02748	3.21 ± 0.14	3.89 ± 0.24	0.83
Plasma protease C1 inhibitor	SERPING1	P05155	9.05 ± 3.04	26.13 ± 5.88	0.35
Hemoglobin subunit beta	HBB	P68871	86.97 ± 13.09	320.97 ± 14.96	0.27